Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Lung Neoplasms 6Solid Tumor 1Small Cell Lung Carcinoma 1Resectable Non-small Cell Lung Cancer 1Recurrence 1Rare Tumour 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1NSCLC 1Meningeal Carcinomatosis 1Brain Neoplasms 1

Interventions

osimertinib 1Spinal Puncture 1Leukapheresis 1Hematologic Tests 1Blood Specimen Collection 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplastic Cells, Circulating × osimertinib × Clear all
NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Second Affiliated Hospital of Nanchang University

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡